A multicenter, retrospective study on impact of immunotherapy in urothelial carcinoma with bone metastases (Meet-Uro01 Study).

Patrizia Giannatempo,Laura Marandino,Daniele Raggi,Francesco Pierantoni,Marco Maruzzo,Helga Lipari,Giuseppe Luigi Banna,Ugo De Giorgi,Emanuele Naglieri,Sebastiano Buti,Marco Stellato,Francesca Vignani,Giandomenico Roviello,Antonello Veccia,Tania Losanno,Claudia Mucciarini,Sandro Pignata,Andrea Necchi,Massimo Di Maio

A multicenter, retrospective study on impact of immunotherapy in urothelial carcinoma with bone metastases (Meet-Uro01 Study).

2021

Patrizia Giannatempo
Laura Marandino
Daniele Raggi
Francesco Pierantoni
Marco Maruzzo
Helga Lipari
Giuseppe Luigi Banna
Ugo De Giorgi
Emanuele Naglieri
Sebastiano Buti
Marco Stellato
Francesca Vignani
Giandomenico Roviello
Antonello Veccia
Tania Losanno
Claudia Mucciarini
Sandro Pignata
Andrea Necchi
Massimo Di Maio

401Background: Considerable numbers of patients (pts) with metastatic urothelial carcinoma (mUC) (approximately 25-47%) develop bone metastases (BoM). Their impact on the efficacy of immunotherapy ...

Keywords:

Oncology
Immunotherapy
Metastatic Urothelial Carcinoma
urothelial carcinoma
Medicine
Retrospective cohort study
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations